ETON

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.24
Percentage change -1.68	%

Peers: BMY JNJ LLY MRK NVS PFE REGN SNY VRTX ZTS

| Held by: VTI IWM VXF IWO IWC GSSC RSSL UWM URTY ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	14.41%	Shs Outstand	26.82M	Perf Week	3.09%
Market Cap	375.71M	Forward P/E	10.97	EPS next Y	1.28	Insider Trans	-5.72%	Shs Float	22.95M	Perf Month	-25.83%
Enterprise Value	388.45M	PEG	-	EPS next Q	0.01	Inst Own	52.78%	Short Float	4.88%	Perf Quarter	7.94%
Income	-4.58M	P/S	7.77	EPS this Y	402.22%	Inst Trans	13.92%	Short Ratio	2.72	Perf Half Y	3.24%
Sales	48.33M	P/B	15.37	EPS next Y	181.62%	ROA	-7.98%	Short Interest	1.12M	Perf YTD	5.18%
Book/sh	0.91	P/C	21.57	EPS next 5Y	-	ROE	-22.95%	52W High	21.48 -34.78%	Perf Year	321.99%
Cash/sh	0.65	P/FCF	68.06	EPS past 3/5Y	-23.90% 32.22%	ROIC	-8.41%	52W Low	3.22 335.09%	Perf 3Y	373.31%
Dividend Est.	-	EV/EBITDA	1253.08	Sales past 3/5Y	21.35% 109.83%	Gross Margin	58.49%	Volatility	6.26% 6.17%	Perf 5Y	139.08%
Dividend TTM	-	EV/Sales	8.04	EPS Y/Y TTM	-579.73%	Oper. Margin	-3.34%	ATR (14)	0.94	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.43	Sales Y/Y TTM	40.88%	Profit Margin	-9.49%	RSI (14)	35.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.97	EPS Q/Q	-85.71%	SMA20	-5.23%	Beta	1.19	Target Price	29.67
Payout	-	Debt/Eq	1.23	Sales Q/Q	116.95%	SMA50	-15.30%	Rel Volume	1.46	Prev Close	14.25
Employees	31	LT Debt/Eq	1.23	Earnings	May 13 AMC	SMA200	6.84%	Avg Volume	411.44K	Price	14.01
IPO	Nov 13, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-212.57% 14.15%	Trades		Volume	600,219	Change	-1.68%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-25	Reiterated	H.C. Wainwright	Buy	$17 → $33
Jan-10-25	Initiated	B. Riley Securities	Buy	$21
Jan-06-25	Reiterated	H.C. Wainwright	Buy	$15 → $17
Sep-04-24	Resumed	H.C. Wainwright	Buy	$9
May-06-24	Initiated	Craig Hallum	Buy	$8
Oct-14-21	Resumed	B. Riley Securities	Buy	$10
Jan-04-21	Reiterated	H.C. Wainwright	Buy	$20 → $15
Sep-20-19	Initiated	B. Riley FBR	Buy	$13.50
Jun-10-19	Initiated	H.C. Wainwright	Buy	$15

Jun-27-25 06:50AM	Eton Pharmaceuticals Announces Addition to Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
Jun-02-25 12:00PM	Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why (Zacks)
08:50AM	Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-29-25 07:12AM	FDA approves Etons application for hydrocortisone oral solution (Pharmaceutical Technology) -5.78%
May-28-25 11:49PM	Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency (Insider Monkey)
05:28PM	Loading…
05:28PM	Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral Solution (GlobeNewswire)
May-14-25 04:30PM	Eton Pharmaceuticals to Participate at Upcoming Investor Conferences (GlobeNewswire) +15.07%
09:19AM	Q1 2025 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ... (GuruFocus.com)
May-13-25 05:15PM	Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-12-25 09:32AM	Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 10:00AM	Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline (Zacks)
May-01-25 04:30PM	Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 (GlobeNewswire)
10:01AM	Loading…
10:01AM	Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release (Zacks)
Apr-28-25 06:50AM	Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) (GlobeNewswire)
Apr-01-25 07:00AM	Eton Pharmaceuticals Out-Licenses International Rights to Increlex (GlobeNewswire)
Mar-21-25 10:56PM	Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-18-25 08:00AM	Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:50AM	Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Mar-14-25 06:50AM	Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 (GlobeNewswire) +6.71%
Mar-04-25 06:50AM	Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 (GlobeNewswire)
Mar-03-25 06:50AM	Eton Pharmaceuticals Announces Commercial Launch of Galzin (zinc acetate) Capsules (GlobeNewswire)
Feb-10-25 07:11AM	Eton secures US patent for diabetes insipidus treatment (Pharmaceutical Technology)
Feb-07-25 06:50AM	Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 (GlobeNewswire)
Feb-06-25 06:50AM	Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 (GlobeNewswire)
Jan-25-25 09:15AM	Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum (TipRanks)
Jan-24-25 04:17AM	Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? (Zacks)
Jan-15-25 01:46PM	Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey) +6.56%
06:50AM	Loading…
Jan-03-25 06:50AM	Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin (GlobeNewswire) -9.15%
Dec-20-24 06:50AM	Eton Pharmaceuticals Closes Acquisition of Increlex (mecasermin injection) (GlobeNewswire)
Dec-17-24 06:50AM	Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial (GlobeNewswire)
Dec-03-24 06:50AM	Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer (GlobeNewswire) -5.14%
Nov-26-24 09:48AM	Eton acquires US rights to neonatal diabetes treatment from AMMTeK (Pharmaceutical Technology)
06:55AM	Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK (TipRanks)
Nov-25-24 06:50AM	Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) (GlobeNewswire) +7.12%
Nov-13-24 07:09AM	Q3 2024 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +15.59%
02:18AM	Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
Nov-12-24 04:01PM	Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results (GlobeNewswire) -5.56%
Nov-11-24 07:18AM	What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings (GuruFocus.com) +10.59%
Nov-07-24 07:00AM	Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire)
Nov-06-24 04:30PM	Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (GlobeNewswire)
Oct-29-24 09:30AM	Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum (TipRanks)
Oct-28-24 11:01AM	Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc. (GuruFocus.com)
Oct-17-24 04:15PM	SWK Holdings Provides Portfolio Update (ACCESSWIRE)
Oct-09-24 01:02AM	Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares (GuruFocus.com)
Oct-03-24 06:30AM	Eton Pharmaceuticals, Inc to Acquire Increlex (mecasermin injection) from Ipsen (GlobeNewswire) +16.33%
Sep-13-24 02:22AM	Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc. (GuruFocus.com) +6.85%
Aug-22-24 04:30PM	Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) +6.82%
Aug-08-24 09:59PM	ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-30-24 05:30PM	Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)
Jul-15-24 04:05PM	Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire) +7.49%
May-10-24 10:11AM	Q1 2024 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 04:01PM	Eton Pharmaceuticals Reports First Quarter 2024 Financial Results (GlobeNewswire) -7.66%
May-01-24 04:05PM	Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference (GlobeNewswire) +5.14%
Apr-30-24 11:21AM	Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400 (MT Newswires)
07:00AM	Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire)
Apr-29-24 04:30PM	Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (GlobeNewswire)
Mar-22-24 02:20AM	Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE (ACCESSWIRE) +9.39%
02:00AM	Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE for Phenylketonuria (GlobeNewswire)
Mar-15-24 03:10PM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript (Insider Monkey) -13.68%
09:34AM	Q4 2023 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:35PM	Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ... (GuruFocus.com)
05:15PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-29-24 04:01PM	Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 (GlobeNewswire)
Feb-26-24 08:19AM	Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-21-24 06:50AM	Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation (GlobeNewswire)
Feb-02-24 06:50AM	Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules (GlobeNewswire)
Jan-16-24 07:52AM	3 Pharma Stocks for January 2024 Profits (Entrepreneur: Stocks) -6.41%
Nov-11-23 11:09AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:01PM	Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results (GlobeNewswire) -15.23%
Oct-30-23 06:50AM	Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (GlobeNewswire)
Oct-23-23 05:16AM	Eton Pharma (ETON) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-18-23 08:00AM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Oct-04-23 06:50AM	Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone (GlobeNewswire)
Sep-22-23 12:04PM	Immix (IMMX) Up on Orphan Drug Tag for AL Amyloidosis Therapy (Zacks)
Sep-20-23 09:40AM	Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-12-23 08:50AM	Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON) (Zacks)
Aug-25-23 11:36AM	Eton Pharmaceuticals (ETON): A Modestly Undervalued Stock Worth Your Attention (GuruFocus.com)
Aug-23-23 06:50AM	Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-16-23 09:15AM	Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run? (Zacks) -8.44%
Aug-13-23 07:52AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 12:44PM	Q2 2023 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +38.08%
Aug-10-23 05:40PM	Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-08-23 10:50AM	Techne (TECH) Meets Q4 Earnings Estimates (Zacks)
Aug-01-23 04:05PM	Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023 (GlobeNewswire)
Jul-17-23 04:05PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Jul-15-23 08:40AM	The past three years for Eton Pharmaceuticals (NASDAQ:ETON) investors has not been profitable (Simply Wall St.)
Jun-28-23 06:50AM	Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection (GlobeNewswire) -17.33%
May-16-23 11:35AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-11-23 05:35PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-10-23 06:50AM	Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution) (GlobeNewswire)
May-03-23 04:05PM	Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 (GlobeNewswire)

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Krempa David	Chief Business Officer	Jun 12 '25	Sale	14.92	16,977	253,297	629,669	Jun 16 04:56 PM
Krempa David	Chief Business Officer	Jun 16 '25	Sale	14.73	10,223	150,585	612,646	Jun 16 04:56 PM
Krempa David	Chief Business Officer	Jun 13 '25	Sale	14.77	6,800	100,436	622,869	Jun 16 04:56 PM
Opaleye Management Inc.	10% Owner	Jun 10 '25	Buy	15.82	7,930	125,484	2,770,000	Jun 12 04:32 PM
Krempa David	Officer	Jun 12 '25	Proposed Sale	15.00	40,000	600,000		Jun 12 04:21 PM
BRYNJELSEN SEAN	President & CEO	Jun 03 '25	Sale	17.51	70,000	1,225,911	3,013,513	Jun 05 05:15 PM
BRYNJELSEN SEAN	President & CEO	Jun 04 '25	Sale	17.00	70,000	1,190,000	2,943,513	Jun 05 05:15 PM
BRYNJELSEN SEAN	President & CEO	Jun 05 '25	Sale	16.81	70,000	1,176,700	2,873,513	Jun 05 05:15 PM
BRYNJELSEN SEAN	Officer	Jun 03 '25	Proposed Sale	18.00	210,000	3,780,000		Jun 03 04:00 PM
RIEDEL NORBERT G	Director	Jan 03 '25	Option Exercise	3.65	102,400	373,842	162,145	Jan 06 04:22 PM
Opaleye Management Inc.	10% Owner	Oct 23 '24	Buy	7.98	10,000	79,814	2,770,000	Oct 25 04:05 PM
Opaleye Management Inc.	10% Owner	Oct 08 '24	Buy	7.03	33,970	238,782	2,760,000	Oct 08 06:34 PM
Opaleye Management Inc.	10% Owner	Oct 04 '24	Buy	6.77	16,852	114,105	2,720,000	Oct 08 06:34 PM
Opaleye Management Inc.	10% Owner	Oct 07 '24	Buy	7.22	11,248	81,250	2,730,000	Oct 08 06:34 PM
Opaleye Management Inc.	10% Owner	Sep 10 '24	Buy	4.65	57,500	267,375	2,660,000	Sep 12 07:31 PM
Opaleye Management Inc.	10% Owner	Sep 11 '24	Buy	4.75	50,000	237,500	2,705,000	Sep 12 07:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Eton Pharmaceuticals Inc

Upgrade your FINVIZ experience